HMG CO-A REDUCTASE INHIBITOR ENHANCEMENT OF BONE AND CARTILAGE

摘要

Methods of enhancing skeletal framework tissue are provided by treating a site requiring enhancement with an HMG-CoA reductase inhibitor at a dosage and for a duration that enhances the tissue while avoiding excess of the inhibitor and degradation of the enhancement.